Novel melanocortin receptor agonists and antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 209/18 (2006.01) A61K 31/404 (2006.01) A61P 43/00 (2006.01) C07D 209/14 (2006.01) C07D 209/42 (2006.01) C07D 209/88 (2006.01) C07D 213/82 (2006.01) C07D 401/06 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01)

Patent

CA 2398728

The present invention relates to novel aromatic amines of general formula (I) and to the use of these amines for the treatment of obesity, anorexia, inflammation, mental disorders an other diseases associated with the melanocortin receptors or related systems, e.g. the melanocyte stimulating hormones.

L'invention concerne de nouvelles amines aromatiques représentées par la formule générale (I) et l'utilisation de ces amines pour traiter l'obésité, l'anorexie, l'inflammation, des troubles mentaux et d'autres affections associées aux récepteurs des mélanocortines ou à des systèmes correspondants, p. ex. les hormones de stimulation des mélanocytes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel melanocortin receptor agonists and antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel melanocortin receptor agonists and antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel melanocortin receptor agonists and antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1716084

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.